MHRP and collaborators at two sites in Thailand are participating in the MAGI study, a NIAID-sponsored Phase 2 trial of a meningococcal Group B vaccine, Bexsero, in preventing gonococcal infection.
In 2021, MHRP, along with the Armed Forces Research Institute for Medical Sciences (AFRIMS) and the Department of Defense HIV/AIDS Prevention Program (DHAPP), received PEPFAR funding to develop a military-military partnership in the Philippines.
MHRP began enrolling participants in Homa Bay, Kenya, for a new prospective observational study of HIV and other sexually transmitted infections (STIs) called the Multinational Observational Cohort of HIV and Other Infections (MOCHI).
MHRP and collaborators recently launched a Phase 1 trial in Thailand that will evaluate two HIV vaccine candidates with and without the Army's novel ALFQ adjuvant to gain insight into late boosting strategies and the effects of fractional dosing.
February 11 is International Women and Girls in Science Day, a day to create awareness of the STEM gap and recognize the roles women in STEM play in advancing their fields.
